[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Heart Failure Drugs Market Report 2018

January 2018 | 96 pages | ID: U6E0CD27D40EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Heart Failure Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Heart Failure Drugs in these regions, from 2013 to 2025 (forecast).
United States Heart Failure Drugs market competition by top manufacturers/players, with Heart Failure Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Amgen
  • AstraZeneca
  • Bayer
  • Novartis
  • Gilead
  • GlaxoSmithKline
  • Pfizer
  • Teva Pharmaceutical industries
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Beta blockers
  • ARBs
  • ACE inhibitors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Drugstore
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Heart Failure Drugs Market Report 2018

1 HEART FAILURE DRUGS OVERVIEW

1.1 Product Overview and Scope of Heart Failure Drugs
1.2 Classification of Heart Failure Drugs by Product Category
  1.2.1 United States Heart Failure Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Heart Failure Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Beta blockers
  1.2.4 ARBs
  1.2.5 ACE inhibitors
1.3 United States Heart Failure Drugs Market by Application/End Users
  1.3.1 United States Heart Failure Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Heart Failure Drugs Market by Region
  1.4.1 United States Heart Failure Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Heart Failure Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Heart Failure Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Heart Failure Drugs Status and Prospect (2013-2025)
  1.4.5 New England Heart Failure Drugs Status and Prospect (2013-2025)
  1.4.6 The South Heart Failure Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Heart Failure Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Heart Failure Drugs (2013-2025)
  1.5.1 United States Heart Failure Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Heart Failure Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES HEART FAILURE DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Heart Failure Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Heart Failure Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Heart Failure Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Heart Failure Drugs Market Competitive Situation and Trends
  2.4.1 United States Heart Failure Drugs Market Concentration Rate
  2.4.2 United States Heart Failure Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Heart Failure Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEART FAILURE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Heart Failure Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Heart Failure Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Heart Failure Drugs Price by Region (2013-2018)

4 UNITED STATES HEART FAILURE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Heart Failure Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Heart Failure Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Heart Failure Drugs Price by Type (2013-2018)
4.4 United States Heart Failure Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES HEART FAILURE DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Heart Failure Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Heart Failure Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEART FAILURE DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Heart Failure Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Heart Failure Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.2 Heart Failure Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Heart Failure Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Gilead
  6.5.2 Heart Failure Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Gilead Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
  6.6.2 Heart Failure Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Heart Failure Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical industries
  6.8.2 Heart Failure Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceutical industries Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 HEART FAILURE DRUGS MANUFACTURING COST ANALYSIS

7.1 Heart Failure Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Heart Failure Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Heart Failure Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Heart Failure Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEART FAILURE DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Heart Failure Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Heart Failure Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Heart Failure Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Heart Failure Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Heart Failure Drugs
Figure United States Heart Failure Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Heart Failure Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Beta blockers Product Picture
Figure ARBs Product Picture
Figure ACE inhibitors Product Picture
Figure United States Heart Failure Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Heart Failure Drugs by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Heart Failure Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Heart Failure Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Heart Failure Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Heart Failure Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Heart Failure Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Heart Failure Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Heart Failure Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Heart Failure Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Heart Failure Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Heart Failure Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Heart Failure Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Heart Failure Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Heart Failure Drugs Sales Share by Players/Suppliers
Figure 2017 United States Heart Failure Drugs Sales Share by Players/Suppliers
Figure United States Heart Failure Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Heart Failure Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Heart Failure Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Heart Failure Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Heart Failure Drugs Revenue Share by Players/Suppliers
Table United States Market Heart Failure Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Heart Failure Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Heart Failure Drugs Market Share of Top 3 Players/Suppliers
Figure United States Heart Failure Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Heart Failure Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Heart Failure Drugs Product Category
Table United States Heart Failure Drugs Sales (K Units) by Region (2013-2018)
Table United States Heart Failure Drugs Sales Share by Region (2013-2018)
Figure United States Heart Failure Drugs Sales Share by Region (2013-2018)
Figure United States Heart Failure Drugs Sales Market Share by Region in 2017
Table United States Heart Failure Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Heart Failure Drugs Revenue Share by Region (2013-2018)
Figure United States Heart Failure Drugs Revenue Market Share by Region (2013-2018)
Figure United States Heart Failure Drugs Revenue Market Share by Region in 2017
Table United States Heart Failure Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Heart Failure Drugs Sales (K Units) by Type (2013-2018)
Table United States Heart Failure Drugs Sales Share by Type (2013-2018)
Figure United States Heart Failure Drugs Sales Share by Type (2013-2018)
Figure United States Heart Failure Drugs Sales Market Share by Type in 2017
Table United States Heart Failure Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Heart Failure Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Heart Failure Drugs by Type (2013-2018)
Figure Revenue Market Share of Heart Failure Drugs by Type in 2017
Table United States Heart Failure Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Heart Failure Drugs Sales Growth Rate by Type (2013-2018)
Table United States Heart Failure Drugs Sales (K Units) by Application (2013-2018)
Table United States Heart Failure Drugs Sales Market Share by Application (2013-2018)
Figure United States Heart Failure Drugs Sales Market Share by Application (2013-2018)
Figure United States Heart Failure Drugs Sales Market Share by Application in 2017
Table United States Heart Failure Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Heart Failure Drugs Sales Growth Rate by Application (2013-2018)
Table Amgen Basic Information List
Table Amgen Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure Amgen Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure Amgen Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure AstraZeneca Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure Bayer Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure Bayer Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure Novartis Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure Novartis Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table Gilead Basic Information List
Table Gilead Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure Gilead Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure Gilead Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure Pfizer Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical industries Basic Information List
Table Teva Pharmaceutical industries Heart Failure Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical industries Heart Failure Drugs Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical industries Heart Failure Drugs Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical industries Heart Failure Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Heart Failure Drugs
Figure Manufacturing Process Analysis of Heart Failure Drugs
Figure Heart Failure Drugs Industrial Chain Analysis
Table Raw Materials Sources of Heart Failure Drugs Major Players/Suppliers in 2017
Table Major Buyers of Heart Failure Drugs
Table Distributors/Traders List
Figure United States Heart Failure Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Heart Failure Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Heart Failure Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Heart Failure Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Heart Failure Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Heart Failure Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Heart Failure Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Heart Failure Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Heart Failure Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Heart Failure Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Heart Failure Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Heart Failure Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Heart Failure Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories